Assignee
DYAX CORP
US·120 granted patents·63 pending applications·4,623 citations·filing 1994–2020
Top patents by PatentIndex Score
183 records- 0198US7851442B2Prevention and reduction of blood lossDYAX CORP·Filed 2007·Granted Dec 14, 2010·46 cites·14 claims
- 0298US7811991B2Prevention and reduction of blood lossDYAX CORP·Filed 2007·Granted Oct 12, 2010·48 cites·15 claims
- 0398US7235530B2Kallikrein inhibitors and anti-thrombolytic agents and uses thereofDYAX CORP·Filed 2005·Granted Jun 26, 2007·103 cites·21 claims
- 0498US6423498B1Variegated Kunitz domain peptide library and uses thereofDYAX CORP·Filed 2000·Granted Jul 23, 2002·143 cites·4 claims
- 0597US10370453B2Plasma kallikrein binding proteinsDYAX CORP·Filed 2015·Granted Aug 6, 2019·25 cites·9 claims
- 0697US9034601B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2013·Granted May 19, 2015·26 cites·25 claims
- 0797US8044175B2Peptides that specifically bind HGF receptor (CMET) and uses thereofDYAX CORP·Filed 2008·Granted Oct 25, 2011·44 cites·4 claims
- 0897US7919462B2Inhibitors of human plasmin derived from the Kunitz domainsDYAX CORP·Filed 2007·Granted Apr 5, 2011·29 cites·14 claims
- 0997US7628983B2Kallikrein-binding “Kunitz domain” proteins and analogues thereofDYAX CORP·Filed 2006·Granted Dec 8, 2009·48 cites·13 claims
- 1097US7276480B1Prevention and reduction of blood lossDYAX CORP·Filed 2005·Granted Oct 2, 2007·76 cites·4 claims
- 1197US5837500ADirected evolution of novel binding proteinsDYAX CORP·Filed 1995·Granted Nov 17, 1998·595 cites·43 claims
- 1297US5663143AEngineered human-derived kunitz domains that inhibit human neutrophil elastaseDYAX CORP·Filed 1994·Granted Sep 2, 1997·272 cites·9 claims
- 1396US10059936B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2016·Granted Aug 28, 2018·7 cites·16 claims
- 1496US9556428B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2015·Granted Jan 31, 2017·8 cites·40 claims
- 1596US7064107B2Prevention and reduction of blood lossDYAX CORP·Filed 2003·Granted Jun 20, 2006·86 cites·8 claims
- 1696US6071723AInhibitors of human plasmin derived from the Kunitz domainsDYAX CORP·Filed 1999·Granted Jun 6, 2000·78 cites·20 claims
- 1796US6057287AKallikrein-binding "Kunitz domain" proteins and analogues thereofDYAX CORP·Filed 1994·Granted May 2, 2000·125 cites·8 claims
- 1895US11046785B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2019·Granted Jun 29, 2021·11 cites·7 claims
- 1995US10648990B2Diagnosis and treatment of autoimmune diseasesDYAX CORP·Filed 2018·Granted May 12, 2020·7 cites·10 claims
- 2095US9266964B2Method of treating hereditary angioedema using plasma kallikrein binding antibodiesDYAX CORP·Filed 2014·Granted Feb 23, 2016·24 cites·6 claims
- 2195US9260520B2Antibodies to FeRn and uses thereofDYAX CORP·Filed 2014·Granted Feb 16, 2016·18 cites·6 claims
- 2295US8034775B2Kallikrein-inhibitor therapiesDYAX CORP·Filed 2007·Granted Oct 11, 2011·25 cites·15 claims
- 2395US7485297B2Method of inhibition of vascular development using an antibodyDYAX CORP·Filed 2005·Granted Feb 3, 2009·35 cites·30 claims
- 2495US7208293B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2001·Granted Apr 24, 2007·94 cites·13 claims
- 2595US7118879B2Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target materialDYAX CORP·Filed 2002·Granted Oct 10, 2006·80 cites·26 claims
- 2695US6989369B2Kunitz domain peptidesDYAX CORP·Filed 2003·Granted Jan 24, 2006·53 cites·27 claims
- 2795US6333402B1Kallikrein-binding “Kunitz domain” proteins and analogues thereofDYAX CORP·Filed 1999·Granted Dec 25, 2001·115 cites·7 claims
- 2895US6010880AInhibitors of human plasmin derived from the kunitz domainsDYAX CORP·Filed 1995·Granted Jan 4, 2000·102 cites·16 claims
- 2995US5994125AKallikrein-inhibiting "Kunitz Domain" proteins and analogues thereofDYAX CORP·Filed 1998·Granted Nov 30, 1999·112 cites·7 claims
- 3095US5795865AKallikrein-inhibiting "kunitz domain" proteins and analogues thereofDYAX CORP·Filed 1995·Granted Aug 18, 1998·145 cites·13 claims
- 3194US7704949B2Kallikrein-inhibitor therapiesDYAX CORP·Filed 2006·Granted Apr 27, 2010·33 cites·16 claims
- 3294US7329737B2Antibodies that bind hK-1DYAX CORP·Filed 2005·Granted Feb 12, 2008·54 cites·17 claims
- 3394US7261876B2Multivalent constructs for therapeutic and diagnostic applicationsDYAX CORP·Filed 2003·Granted Aug 28, 2007·33 cites·33 claims
- 3494US7211240B2Multivalent constructs for therapeutic and diagnostic applicationsDYAX CORP·Filed 2003·Granted May 1, 2007·52 cites·67 claims
- 3594US7153829B2Kallikrein-inhibitor therapiesDYAX CORP·Filed 2004·Granted Dec 26, 2006·62 cites·18 claims
- 3694US6979538B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2001·Granted Dec 27, 2005·80 cites·19 claims
- 3794US6103499AInhibitors of human plasmin derived from the Kunitz domainsDYAX CORP·Filed 1999·Granted Aug 15, 2000·79 cites·16 claims
- 3893US10577599B2Multi-chain eukaryotic display vectors and uses thereofDYAX CORP·Filed 2018·Granted Mar 3, 2020·3 cites·12 claims
- 3993US10336832B2Methods of inhibiting plasma kallikrein in edema patientDYAX CORP·Filed 2014·Granted Jul 2, 2019·13 cites·7 claims
- 4093US7893007B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2008·Granted Feb 22, 2011·22 cites·19 claims
- 4193US7718617B2Methods for preserving organs and tissuesDYAX CORP·Filed 2007·Granted May 18, 2010·43 cites·9 claims
- 4293US7550427B2Poly-pegylated protease inhibitorsDYAX CORP·Filed 2006·Granted Jun 23, 2009·31 cites·48 claims
- 4393US7413537B2Directed evolution of disulfide-bonded micro-proteinsDYAX CORP·Filed 2002·Granted Aug 19, 2008·40 cites·34 claims
- 4493US7244592B2Ligand screening and discoveryDYAX CORP·Filed 2003·Granted Jul 17, 2007·64 cites·15 claims
- 4593US6984373B2Fibrin binding moieties useful as imaging agentsDYAX CORP·Filed 2001·Granted Jan 10, 2006·57 cites·59 claims
- 4692US10914747B2Immunoassay to detect cleaved high molecular weight kininogenDYAX CORP·Filed 2016·Granted Feb 9, 2021·6 cites·50 claims
- 4792US10428158B2Compositions and methods for treatment of diabetic macular edemaDYAX CORP·Filed 2015·Granted Oct 1, 2019·14 cites·9 claims
- 4892US7166576B2Methods for preserving organs and tissuesDYAX CORP·Filed 2003·Granted Jan 23, 2007·72 cites·3 claims
- 4992US6953674B2Inhibitors of human plasmin derived from the kunitz domainsDYAX CORP·Filed 2002·Granted Oct 11, 2005·31 cites·56 claims
- 5091US9862768B2Methods of producing antibodies to neonatal Fc receptor (FcRn)DYAX CORP·Filed 2016·Granted Jan 9, 2018·7 cites·12 claims
Showing the top 50 of 183 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →